Form 4: Arvinas Inc. Executive David K. Loomis Reports Stock and Option Grants

David K. Loomis, Chief Accounting Officer of Arvinas Inc., reports the acquisition of restricted stock units and stock options.

Summary

• On February 13, 2025, David K. Loomis, Chief Accounting Officer of Arvinas Inc., was granted 10,584 restricted stock units (RSUs) and an option to purchase 16,176 shares of common stock.
• The RSUs vest over four years, with 25% vesting annually on February 13th from 2026 to 2029, contingent upon continued service.
• The stock options, with an exercise price of $17.67, also vest over four years, with 1/4 vesting on February 13, 2026, and the remainder in equal monthly installments until February 13, 2029, subject to continued service.
• Following these transactions, Loomis directly owns 18,624 shares of Arvinas Inc. common stock and holds options for 16,176 shares.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The grant of stock options and RSUs is a standard practice and indicates confidence in the company's future, but it's not a major event that would drastically alter investor sentiment.

Positives

• The grant of RSUs and stock options to a key executive like the Chief Accounting Officer suggests an incentive alignment with the company's long-term performance.
• The vesting schedule encourages continued service and commitment from the executive.

Future Outlook

The vesting of the RSUs and stock options is contingent upon the reporting person's continued service with the Issuer on each vesting date.

Industry Context

Stock and option grants are a common practice in the biotechnology industry to incentivize and retain key executives. These grants align executive compensation with the company's stock performance and long-term success.

Comparison to Industry Standards

• Stock option and RSU grants are standard compensation components for executives in biotech companies like Arvinas.
• Comparable companies such as BioNTech, Moderna, and Gilead Sciences also utilize stock options and RSUs as part of their executive compensation packages.
• The vesting schedules described are typical for these types of grants, aligning with industry norms for incentivizing long-term performance.

Stakeholder Impact

• Shareholders may view the grants positively as they align executive interests with company performance.
• Employees may see this as a positive sign of the company's commitment to its leadership.

Key Dates

Keywords

Arvinas Inc., David K. Loomis, stock options, restricted stock units, Form 4, insider trading, executive compensation